Full Length Research Paper
References
|
Andia A, Alassane S, Brah S (2016). La Polyarthrite Rhumatoïde à l'Hôpital National de Niamey. A propos de 42 cas. RAFMI 3(2):29-32. |
|
|
Arimone Y, Bidault I, Dutertre JP, Gérardin M, Guy C, Françoise Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Théophile H, Marie-Blanche Valnet-Rabier M-B (2011). Réactualisation de la méthode française d'imputabilité des effets indésirables des médicaments. Thérapie 66(6):517-525. |
|
|
Bluett J, Morgan C, Thurston L, Plant D, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD, Cordingley L, Barton A (2015). Impact of inadequation adherence on response to subcutaneously administrered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Cohort. Rheumatology 54(3):494-499. |
|
|
Bluett J, Riba-Garcia I, Verstappen SM, Wendling T, Ogungbenro K, Unwin RD, Barton A (2019). Development and validation of a methotrexate adherence assay. Annals Rheumatic Diseases 0:1-6. |
|
|
Contreras-Yanez I, Ponce De Leon S, Cabiedes J, Rull-Gabayet M, Pascual-Ramos V (2010). Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. The American Journal of the Medical Sciences 340(4):282-290 |
|
|
Dossa AR, Grégoire JP, Lauzier S, Guénette L, Sirois C, Moisan J. (2015) Association Between Loyalty to Community Pharmacy and Medication Persistence and Compliance, and the Use of Guidelines-Recommended Drugs in Type 2 Diabetes: A Cohort Study. Medicine 94(27):1082. |
|
|
Gabriel SE (2001). The epidemiology of rheumatoid arthritis. Rheumatic Disease Clinics of North America 27(2):269-281. |
|
|
Hayem G (2002). La polyarthrite rhumatoïde. Revue du Praticien. 52:2037-2047. |
|
|
Houzou P, Oniankitan O, Kakpovi K, Koffi-Tessio VES, Tagbor KC, Fianyo E, Mijiyawa M (2013). Profil des affections rhumatismales chez 13517 patients ouest-africains. Tunis Médical 91(1):16-20. |
|
|
Igor R, Sidhu S, Papana A, Meng S-J, Xin-Wei Y, Wang W, Campbell-Page RM, Demaio AR, Nair H, Sridhar D, Theodoratou E, Dowman B, Adeloye D, Majeed A, Car J, Campbell H, Wang W, Chan KY. (2015). Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis. Journal of Global Health 5(1). |
|
|
Le Loët X, Goëb V, Lequerré T (2006). Polyarthrite rhumatoïde. EMC - AKOS (Traité de Médecine) , pp. 1-8. |
|
|
Lekpa FK, Ndongo S, Moreira-Diop T (2012). La Polyarthrite Rhumatoide en milieu rural Au Sénegal. Ed. Univ. Européenne. 60 p. ISBN-13: 978-3838187242. |
|
|
Ouédraogo DD, Ntsiba H, Tiendrébéogo Zabsonré J, Tiéno H, Bokossa LI, Kaboré F, Drabo J. (2014). Clinical spectrum of rheumatologic diseases in a department of rheumatology in Ouagadougou (Burkina Faso). Clinical Rheumatology 33(3):385-389. |
|
|
Ouédraogo DD, Tiendrébéogo J, Guiguimdé PL, Nikiéma PI, Ouédraogo D, Kaboré F, Zongo E, Hayem G (2017).Periodontal disease in patients with rheumatoid arthritis in Sub-Saharan Africa: A case-control study. Joint Bone Spine 84(1):113-114. |
|
|
Sany J, Bourgeois P, Saraux A, Durieux S, Lafuma A, Daurès JP, Guillemin F, Sibilia J. (2004). Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists. Annals of the rheumatic diseases 63(10):1235-1240. |
|
|
Shinde CG, Venkatesh MP, Kumar TM, Shivakumar HG (2014). Methotrexate: a gold standard for treatment of rheumatoid arthritis. Journal of Pain and Palliative Care Pharmacotherapy 28(4):351-358. |
|
|
Silman A.J, Pearson JE (2002). Epidemiology and genetics of rheumatoidarthritis. Arthritis Research 4(S3):265-272 |
|
|
Slimani S, Ladjouze-Rezig A (2014). Prevalence of rheumatoid arthritis in an urban population of Algeria: a prospective study. Rheumatology 53(3):571-573. |
|
|
Sweetman SC (2011). Martindale: The complete drug reference, 37th ed., editor. London, England, UK: Pharmaceutical Press 4142 p. |
|
|
Weinblatt EM (2013). Methotrexate in rheumatoid arthritis: a quarter century of development. Transactions of the American Clinical and Climatological Association 124:16 |
|
|
World Health Organization (WHO) (2003). Adherence to long-term therapies: evidence for action. Geneva 211 p. |
|
|
Yaméogo PS (2016). Formes tardives de la polyarthrite rhumatoide: Etude comparative avec la polyarthrite rhumatoide du sujet jeune. Mémoire de DES n°65. Université de Ouagadougou. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
